Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals
International Journal of Cancer Oct 13, 2019
Madathil S, Rousseau MC, Joseph L, et al. - Data from 631 ever-smoker individuals of a hospital-based case-control study done in four major hospitals in Montréal, Canada, of cases (n = 320), incident, histologically validated, primary squamous cell carcinomas and to controls (n = 311) were analyzed in order to examine the latency and life course impacts of tobacco smoking on risk of head and neck cancers (HNC) among HPV-positive (HPV+ve) and negative (HPV-ve) people. For HPV+ve cases and controls, retrospective smoking trajectories had comparable shapes. Among both HPV+ve and HPV-ve individuals, exposure to tobacco smoking even 40 years prior to the diagnosis was related to an elevated HNC risk. Among HPV+ve people, in comparison with afterward, the impact of smoking prior to the start of sexual activity was greater. Among HPV-ve individuals, this pattern of relationship was less profound. Therefore, relative to HNC risk, temporal interactions may endure between oral HPV infection and life course smoking trajectories.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries